4//SEC Filing
PRENDERGAST JOHN K A 4
Accession 0001553350-22-000010
CIK 0001476963other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:20 PM ET
Size
8.2 KB
Accession
0001553350-22-000010
Insider Transaction Report
Form 4
PRENDERGAST JOHN K A
Director
Transactions
- Award
Stock Option (right to buy)
2021-12-30+129,820→ 129,820 totalExercise: $4.06From: 2022-01-13Exp: 2031-12-29→ Common Stock (129,820 underlying) - Other
Stock Option (right to buy)
2021-12-30−129,820→ 0 totalExercise: $4.06From: 2022-01-13Exp: 2031-12-12→ Common Stock (129,820 underlying)
Footnotes (2)
- [F1]On December 30, 2021, the board of directors of Heat Biologics, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Dr. Prendergast on December 13, 2021 covering 129,820 shares under the Company's 2018 Stock Incentive Plan (the "Plan") and granted new stock options under the Plan, on substantially similar terms to the rescinded stock options, which new stock options are subject to forfeiture in the event an amendment to increase the number of shares of common stock available for grant under the Plan is not adopted by the Company's stockholders.
- [F2]These stock options vest pro rata on a monthly basis over a twelve- month period commencing 1/13/2022
Documents
Issuer
HEAT BIOLOGICS, INC.
CIK 0001476963
Entity typeother
Related Parties
1- filerCIK 0001042019
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:20 PM ET
- Size
- 8.2 KB